Literature DB >> 1599815

Mechanisms of tissue destruction and cellular activation in rheumatoid arthritis.

G S Firestein1.   

Abstract

Rheumatoid arthritis is a chronic inflammatory disease of unknown etiology that is marked by synovial inflammation and destruction of articular extracellular matrix. Several studies of the pathogenesis of tissue destruction have focused on the production of metalloproteinases and their inhibitors in synovium as determinants of joint preservation. Also, the role of cytokines in the perpetuation of synovitis and of superantigens in synovial T-cell activation have led to novel hypotheses that attempt to explain abnormalities of synovial structure and function in rheumatoid arthritis. Recent studies that dealt with these topics are briefly reviewed in the context of current paradigms of inflammatory synovitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599815     DOI: 10.1097/00002281-199206000-00012

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  12 in total

1.  Role of enteric bacteria in the pathogenesis of rheumatoid arthritis: evidence for antibodies to enterobacterial common antigens in rheumatoid sera and synovial fluids.

Authors:  S Aoki; K Yoshikawa; T Yokoyama; T Nonogaki; S Iwasaki; T Mitsui; S Niwa
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

2.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

Authors:  Z Han; D L Boyle; L Chang; B Bennett; M Karin; L Yang; A M Manning; G S Firestein
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 3.  FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.

Authors:  A W Thomson; P B Carroll; J McCauley; J Woo; K Abu-Elmagd; T E Starzl; D H Van Thiel
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.

Authors:  N Di Girolamo; A Lloyd; P McCluskey; M Filipic; D Wakefield
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 5.  Matrix metalloproteinase inhibitors: present achievements and future prospects.

Authors:  L J Denis; J Verweij
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 6.  Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.

Authors:  P J Verschure; C J Van Noorden; J Van Marle; W B Van den Berg
Journal:  Histochem J       Date:  1996-12

Review 7.  Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence.

Authors:  In Young Choi; Changhan Lee; Valter D Longo
Journal:  Mol Cell Endocrinol       Date:  2017-01-28       Impact factor: 4.102

8.  Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1beta stimulated rheumatoid synovial fibroblasts.

Authors:  K Migita; T Miyashita; H Ishibashi; Y Maeda; M Nakamura; H Yatsuhashi; H Ida; A Kawakami; T Aoyagi; Y Kawabe; K Eguchi
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes.

Authors:  K B Reda; V Kapur; J A Mollick; J G Lamphear; J M Musser; R R Rich
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 10.  Problems and paradigms in joint pathology.

Authors:  D L Gardner
Journal:  J Anat       Date:  1994-06       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.